Thermo Fisher Scientific Showcases New Clinical and Research Lab Solutions at AACC 2022
Retrieved on:
Monday, July 25, 2022
Research, General Health, Pharmaceutical, Infectious Diseases, Hospitals, Genetics, Health Technology, Science, COVID-19, Biotechnology, Medical Supplies, Practice Management, Health, Transfer, Association, MAS, PPD, Diagnosis, Diversified Pharmaceutical Services, Thermo Fisher Scientific, Laboratory, U.S. FDA, Industry, Health, Elia, Scleroderma, Research, Genetics, Solution, Toxicology, Patheon, LC-MS/MS, TLA, American Association, Tsing Ma Control Area, COVID-19, Mindful Scientific Inc., Kingfisher, EUA, Fisher Scientific, Applied Biosystems, Infection, Â, AACC, Science, Patient, COVID, Ortho, FDA, Control, PCR, Invitrogen, Automation, Emergency Use Authorization, Medical device, Animal, Pharmaceutical industry
AACC 2022 Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.
Key Points:
- AACC 2022 Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.
- During the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2022), being held at the McCormick Place Convention Center in Chicago, July 2428, Thermo Fisher is exhibiting within booth #1413.
- ***The Thermo Scientific Cascadion SM Clinical Analyzer, the Thermo Scientific DRI Fentanyl II Drugs of Abuse Assay and the Thermo Scientific EliA RNA Pol III and EliA Rib-P are For In Vitro Diagnostic Use.
- For more information on all the Thermo Fisher products and solutions exhibited at AACC 2022, please visit: thermofisher.com/aacc .